Drug profile · INN
ivermectin
STROMECTOL
ivermectin (STROMECTOL) is a glutamate-gated chloride channel modulator. Associated with Merck KGaA, Darmstadt, Germany. Route of administration: topical. Current US regulatory status: approved.
Drug details — ivermectin
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.89
Quick answer
ivermectin (STROMECTOL) is a glutamate-gated chloride channel modulator. Associated with Merck KGaA, Darmstadt, Germany. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glutamate-gated chloride channel modulator
Primary target: Glutamate-gated chloride channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is ivermectin?
ivermectin (STROMECTOL) is a glutamate-gated chloride channel modulator. Associated with Merck KGaA, Darmstadt, Germany. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for ivermectin?
STROMECTOL is a marketed brand name for ivermectin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ivermectin?
ivermectin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.